ESPR Next Earnings Date Notes

— Esperion Therapeutics (ESPR) is a biopharmaceutical company focused on developing & commercializing innovative therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C), particularly for those who are either unable or unwilling to use statins. Their flagship products include bempedoic acid tablets (Nexletol™) & the combination therapy Nexlizet™ (bempedoic acid/ezetimibe). For an investor tracking ESPR, it's essential to follow not just quarterly revenue & net product sales, but also prescription growth trends, market penetration metrics, partnerships, regulatory progress in both the US & EU, and milestone or royalty payments from international partners like Daiichi Sankyo. Pipeline developments, especially trial readouts for expanded indications, can be significant catalysts. Importantly, pay special attention to free cash flow & cash runway, as Esperion's path to consistent profitability will heavily depend on managing expenses while scaling up product adoption. On earnings calls, management's guidance on sales growth, updates on reimbursement/access, and commentary regarding ongoing patent or litigation matters are also key to understanding long-term performance & risk. The next projected earnings date for ESPR is 5/5/2026 6:00 am (stay tuned for a confirmed earnings date once announced).

ESPR Next Earnings Date FAQ

On this page we presented the ESPR Next Earnings Date information for Esperion Therapeutics along with recent past earnings dates. For Q4 of 2025, ESPR reported earnings of 0.220/share, with the earnings report taking place on 3/10/2026. For Q3 of 2025, ESPR reported earnings of -0.160/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, ESPR reported earnings of -0.020/share, with the earnings report taking place on 8/5/2025. For Q1 of 2025, ESPR reported earnings of -0.210/share, with the earnings report taking place on 5/6/2025. For Q4 of 2024, ESPR reported earnings of -0.110/share, with the earnings report taking place on 3/4/2025. Based on these past earnings dates, the projected next earnings date for ESPR is 5/5/2026 6:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Esperion Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Esperion Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Esperion Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next ESPR earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ESPR's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ESPR next earnings date.